ESCAPE-NEXT is a multicentre, randomized, double-blinded, placebo-controlled, parallel Group, singledose trial designed to determine the efficacy and safety of nerinetide in participants with acute ischemic stroke undergoing endovascular thrombectomy excluding thrombolysis.
ESCAPE-NEXT is a custom designed Electronic Data Capture (EDC), Randomization and Drug Management (RDM) Interactive Resposive Technology (IRT) developed for the purpose of facilitating the data collection for the ESCAPE-NEXT Trial, while providing the following functions:
Want to know more about DCTMS? Please visit our DCTMS Product page or contact us for a free demo!
Our main areas of expertise are in the Healthcare, Academic, Education as well as the Energy Sector, where we provide solutions for a number of needs: